Clinical, Echocardiographic and Microbiological Evaluation Of Infective Endocarditis In Cardiac Patients
Samir Rafla1*, Youssef Ayoub1, Tarek Elbadawy1
1 Alexandria University, Faculty of Medicine, Cardiology Department, Egypt.
1 Alexandria University, Faculty of Medicine, Cardiology Department, Egypt.
1 Alexandria University, Faculty of Medicine, Cardiology Department, Egypt.
*Corresponding Author
Samir Rafla,
Emeritus professor of cardiology, FACC, FESC, Alexandria University, Faculty of Medicine, Cardiology Department, Egypt.
Tel: 01001495577
E-mail: smrafla@yahoo.com
Received: February 04, 2021; Accepted: February 22, 2021; Published: March 05, 2021
Citation: Samir Rafla, Youssef Ayoub, Tarek Elbadawy. Clinical, Echocardiographic and Microbiological Evaluation Of Infective Endocarditis In Cardiac Patients. Int J Cardiol Res. 2021;07(01):152-157. doi: http://dx.doi.org/10.19070/2470-4563-2100027
Copyright: Samir Rafla© 2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution
and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: We planned to study cases of Infective endocarditis (IE) to define diagnostic criteria and to arrange treatment
protocol.
Methods: The study included 1121 patients, divided in to two groups. Group 1 included 57 patients with IE. Those were collected
over a period of 37 months. Group 2 included 1064 patients who under went cardiac surgery or intervention. Patients
were examined clinically, had ECG, X-ray, Echocardiography, and blood culture. Then they were followed up for six months.
Results: The incidence of IE was 15 patients/ 1000 cardiac admissions. The incidence of Prosthetic Valve Endocarditis
(PVE) was found to be 1.7% of PV replacement. Group I (57 IE patients). Preexisting heart disease was present in 55 patients
(96.5%). The underlying heart diseases were rheumatic in 39 (68.4%). Echocardiography detected vegetations in 86% of patients
with NVE, while only 28.6% of PVE. Positive blood culture was found in 72%. 58% lived the follow-up period (33/57).
The causes of death were heart failure, pulmonary embolism, and cerebral hemorrhage. There was no correlation between the
change in vegetation size and success of therapy.
Conclusions: We defined diagnostic criteria of IE and set the antimicrobial protocol of management.
2.Abbreviation
3.Introduction
4.Endocarditis Diagnostic Criteria - Modified Duke Criteria
5.Methods
6.Results
7.Echocardiography
8.Blood Culture
9.Treatment
10.Discussion
11.Conclusions
12.References
Keywords
Infective Endocarditis; Vegetations; Blood Culture; Rheumatic Heart Disease; Duke Criteria.
Abbreviation: IE: Infective Endocarditis; NVE: Native Valve Endocarditis; PVE: Prosthetic Valve Endocarditis; P.Acc.t.: Pulmonary Acceleration Time.
Introduction
The incidence of IE caused by Staphylococcus aureus has increased,
Characteristics of IE patients have also shifted toward a
higher proportion of prosthetic valves and other cardiac devices,
and a decreasing proportion of rheumatic heart disease [1-6].
Endocarditis Diagnostic Criteria - Modified Duke
Criteria
Diagnostic: 2 Major Criteria and 0 Minor Criteria.
Diagnostic: 1 Major Criteria and 3 Minor Criteria.
Diagnostic: 0 Major Criteria and 5 Minor Criteria.
Major Diagnostic Criteria Positive blood culture for typical infective endocarditis organisms
(S. viridans or S. bovis, HACEK organisms, S. aureus without other
primary site, Enterococcus), from 2 separate blood cultures or
2 positive cultures from samples drawn >12 hours apart.
Echocardiogram with oscillating intracardiac mass on valve or
supporting structures or new partial dehiscence of prosthetic valve or new valvular regurgitation.
Minor Diagnostic Criteria Predisposing heart condition or intravenous drug use.
Temp >38 degrees C (100.4 degrees F).
Vascular Phenomena: Arterial emboli, pulmonary infarcts, mycotic
aneurysms, intracranial bleed, conjunctival hemorrhages,
Janeway lesions.
Immunologic Phenomena: Glomerulonephritis, Osler nodes,
Roth spots, rheumatoid factor.
Microbiological Evidence: Positive blood culture but does not
meet a major criterion as noted above.
We planned to study cases of IE to define diagnostic criteria,
echocardiographic features, to arrange treatment protocol, and to
set criteria for prevention and control of infection.
Methods
The study included 1121 patients, divided in to two groups. Group
1 included 57 patients with IE. Those were collected through aperiod
37 months. Group 2 included 1064 patients who under went
cardiac surgery or intervention. Group 1 patients were submitted
to:
1) Detailed history.
2) Clinical examination.
3) Investigations:
a. Routine laboratory investigations including complete blood
picture.
b. Electrocardiography:
c. Chest x-ray:
d. ECHO-Doppler study: Philips system. The study was done on
admission and repeated during hospital stay, two months later,
and six months when feasible.
All images were recorded on video tape for review. For assessment
of vegetation size, 2-D planimetry was adopted. Other evidence
of endocarditis as ruptured chordae, ring abscess, aneurysm of
the sinus of Valsalva was searched for [7].
e. Blood culture: Three sets of venous samples were with drawn
on admission. This was done before antimicrobial treatment was
started. The samples were taken one hour apart, through separate
venipuncture using iodine / alcohol as skin antiseptic. Each sample
was inoculated on Oxoid Signal bottle [8]. In case of a negative
result, an arterial sample and anothervenous one were taken
and treated as above.
4) Antimicrobial Therapy: According to the Sensitivity tests. In
case of a negative result, empirical therapy was given. In case of
acute IE, antibiotics were started after taking, the first 3 samples.
5) Follow Up: All patients were followed up for six months. Microbiological
cure (a negative culture result) was a necessity.
Group 2 patients were submitted to.
1) Pre-interventional clinical assessment.
2) They were followed for two months post-intervention or surgery
for any feature suggestive of IE. Any one of them who
prove to have the disease was included in group 1.
3) Culture and sensitivity tests from any local source of infection
were done.
Diagnosis of IE was based on Duke Criteria.
Statistical Methods: Data were analyzed using the IBM SPSS
software package. The used tests were: 1- Chi-square test. 2- Fisher’s
Exact or Monte Carlo correction. 3- Student t-test. 4- Paired
t-test.
Results
Group 1 included 57 patients with IE. Group 2 included 1064
patients who underwent cardiac surgery or intervention (e.g. catheterization).
Those were collected through the same period.
Group 1 patients were 41 males (72%) and 16 females (28%) with
a ratio of 2.6: 1. Their ages ranged from 10 to 76 years with a
mean of 30 years. Pre-existing heart disease was present in 55
patients (96.5%). The remaining two patients (3.5%) caught the
infection via repeated IV injections.
The underlying heart diseases were rheumatic in 39 patients
(68.4%). Congenital heart was in 3 patients (5.3%); one of them
had Down’s syndrome, ASD, Ostium primum defect, the second
had tetralogy of Fallot and the third had Marfan’s syndrome. Senile
fibrotic and calcific valves were in 4 patients (7%). PVE occurred
in 7 patients (12.3%). Post~ surgical with no implanted
prostheses were two (3.5%).
The main symptoms encountered in patients with IE were fever
in 53 (93%). Arthralgia was complained of in 37 patients (64.9%).
Dyspnoea was present in 47 patients (82.4%). Symptoms denoting
focal neurological injury due to emboli were in 7 patients (12.3%).
Painful cold extremities due to major arterial embolization were
in 3 patients (5.3%), two of them had femoropopliteal artery occlusion
and one had right axillary artery occlusion. Sudden loss of
vision in one eye occurred in one patient.
The route of entry was known in 29 out of 41 culture positive
patients (70.7%). Oro-dental procedures were in 16 (39%), Otorhino
pharyngeal cause was in 3 (7.3%), lower respiratory infection
was in one patient, skin infection in 4 patients (9.8 %), IV
drug abuse in one patient (24%), genito-urinary instrumentation
in one patient (2.4%), gastrointestinal in one patient (2.4 %) and
peri-operative causes were in two patients (4.9%).
Clinical Signs: Fever in 53 patients (93%). It was absent in four
patients. Clubbing was found in 9 patients (15.8%). The patient
with tetralogy of Fallot was excluded. Skin petechiae in 16 patients
(28.1%). Splinter hemorrhages in 3 patients (5.3%). Janeway
lesions were present in 2 patients (3.5%). Osler’s nodes were
found in 3 patients (5.3%). Conjunctival petechiae in 18 patients
(31.6%). Retinal haemorrhages in 10 patients (17.5%). Roth spots
in 2 patients (3.5%). Splenomegaly in 22 patients (38.6%). During
the period of follow up, four patients developed new murmur
(7%) and six patients (10.5%) showed change of the intensity of
an already present murmur.
Routine laboratory investigations showed that patients with hemoglobin
not more than 11 g/dl were 48 patients (84.2%). Anaemia
was hemolytic in 11 patients (23%). Haemolysis was found in 5
patients with PVE and 6 of those with acute IE.
Leukocytosis (WBC’s>11000/ cu m) was found in 19 patients
(33.3%). Haematuria (Erythrocyturia) was found in 34 patients
(59.6%). Serum creatinine above 1.5 mg /dl was found in 9 patients
(15.8%). Only one patient required dialysis.
Complications: Heart failure in 23 patients (40.4%); Pulmonary embolism in 7
patients (12.3%). Peripheral embolization occurred in three patients
(5.3%). Central nervous system embolization occurred in
7 patients (12.3%). Central retinal artery embolism occurred in
one patient (1.8%). Splenic embolisation occurred in one patient
(1.8%); Renal artery embolization in one patient (1.8%). Renal
failure occurred in 9 patients (15.8%), only one of them required
dialysis. Hepatocellular failure occurred in two patients (3.6%).
Echocardiography
Out of the 57 patients with NVE, vegetations could be visualized
in 43 patients (86%), four of them had also ruptured chordae
tendineae. The total number of patients with ruptured chordae
tendineae was 7 (14%). Endocardial mass not involving the valve
leaflets was in two patients (4%). Ruptured sinus of Valsalva aneurysm
occurred in one patient (2%). Aortic valve ring abscess was
in one patient (2%).
In PVE, vegetations could be seen in two patients (28.6%). Paravalvular
leakage was in 4 patients (57.1%). Rocking or instability
of prosthesis was in two patients (28.6%).
Characteristics Of Vegetations: As regards the site of vegetations, they were visualized on the
mitral valve leaflets in 24 patients (55.8%); those were on the anterior
leaflet in 11 cases, on the posterior leaflet in 9 patients and on
both leaflets in 4 patients. Aortic valve vegetations were seen in 10
patients (23.3%). Both mitral and aortic valves in 7 patients; one
of them had mitral kissing vegetations. Vegetations seen on the
mitral, aortic and tricuspid valves were in one patient (2.3%). Vegetations
seen on the tricuspid valve were in one patient (2.3%).
Masses equivalent to vegetations were seen in two patients.
The size of the vegetations ranged from 53 mm2 to 487 m2. The
sessile vegetations were 37 while the pedunculated were 28 vegetations.
It was found that the vegetation size was affected by the duration
of IE. With duration less than two months, the vegetation size
was: size < 100 mm2: 7 patients; 100- to less than 200:9; 200- to
less than 300: 2 patients. With duration of more than 2 months,
the sizes were < 100: 12; 100- to less than 200:14; 200 to less than
300: 11; >300:10. The results were statistically significant.
The average vegetation Size on the mitral valve leaflets was 291
mm2, on the aortic valve leaflets was 103 mm2, on the tricuspid
valve leaflets were 307 mm2.
The vegetations size was related to the micro-organism; with Str
viridans, the average size was 221 m2, with Str pyogenes, it was
189, with Staph aureus, 309, which is the largest size, with Staph
epidermidis, it was 159, with Pseudomonas cepacia, it was 162
mm2.
Follow up of vegetation size: ECHO for NVE demonstrated no
change in 11 patients (25.6%), decrease in 14 patients (32.6%),
and increase in 12 patients (27.9%).
The decrease in size correlated with embolization in 9 patients.
No correlation was found between change in size and success of
treatment.
Pericardial effusion was demonstrated echocardiographically in
eight patients (14%).
Blood Culture
Repeated blood cultures detected positive results in 41 patients
out of 57 (71.9 %). Negative cultures were in 16 patients (28.1%).
Gram-positive bacteria in 39 patients (95.1%); Gram - negative
bacteria were in 2 cases (4.9 %).
The Gram-positive bacteria were Streptococcus viridans in 23
cases (56.1%). Streptococcus pyogenes was in six cases (14.6%).
Streptococcus pneumoniae was in one patient (2.4%). Streptococcus
bovis was in one patient (2.4%). Enterococcus was in one
patient (2.4%). Staphylococcus aureus was in five cases (12.2%).
Staphylococcus epidermidis was in two cases (4.9%). The Gramnegative
bacteria were Pasteurella multocida in one patient (2.4%)
and Pseudomonas cepacia in one patient (2.4%).
Str. pneumoniae was isolated from a patient with a late PVE. Enterococcus
faecalis was isolated from a patient with a late PVE.
Str. bovis was isolated from a patient with senile fibrocalcific aortic
valve. Pseudomonas cepacia was isolated from a patient with
early double valve replacement.
Treatment
The patients under study were treated medically alone in 41 Patients,
and with both medical and surgical treatment in 16 patients.
Antimicrobial Therapy
Culture-positive cases: Streptococcus viridans: 17 out of 23 isolates
were sensitive to Penicillin (73.9%); these were treated with
penicillin G 3 Million IV 6 hourly for 4 weeks. Six isolates (26.1%)
showed intermediate sensitivity and were treated with penicillin
G 3 Mi 4 hourly for 4 weeks along with gentamicin 80 mg IV
12 hourly for the first two weeks. The dosage of gentamicin was
modified according to the age of the patient and in renal failure
according to the creatinine clearance.
All Streptococcus pyogenes, bovis and pneumoniae were sensitive
to penicillin and so were treated as in the sensitive Streptococcus
viridans.
The enterococcus case was treated with ampicillin-sulbactam
1500 mg IV 8 hourly, along with gentamicin 80 mg IV 12 hourly
and her aortic valve prosthesis was replaced after 4 weeks.
Staph aureus cases: Three patients were treated with piperacillin 2 g IV 8 hourly and
the other patient was treated with cephapirin 1 g IV 8 hourly
along with gentamicin 80 mg IV 12 hourly and rifampicin 300
orally 12 hourly.
The patient with Pasteurella multocida IE was treated with sulfamethoxazole-
trimethoprim 800 mg-160 mg orally 12 hourly and
tetracycline 500 mg orally 6 hourly for 4 weeks.
The patient with Pseudomonas cepacia 113 was treated with
piperacillin 2 g N 8 hourly and amikacin 0.5 g IV 12 hourly.
Culture negative IE: For NVE with subacute course, penicillin G 3 Mi IV 4 hourly for
4 weeks and gentamicin 80 mg 1V 8 hourly for the first 2 weeks.
For NVE with acute course, ampicillin-sulbactam 1500 IV 8
hourly along with gentamicin 80 mg IV 8 hourly for 4 weeks.
In case there is no adequate response in 1 week and in PVE rifampicin
300 mg orally 12 hourly is added.
Prognostic Determinants After six months follow up, 24 patients were dead (42%). The
remaining 33 (58%) were alive with cure rate of 100% (survival
58%). Out of the 33 patients who survived, 16 underwent prosthetic
valve replacement with good prognosis.
The factors implicated in prognosis were:
1. Predisposing Disease: All patients with congenital heart disease lived the follow up period
(3/3 = 100%).
Patients with PV had 57% survival (4/7). IV drug IE had 50%
survival (1/2).
Patients with senile fibrotic and calcific valves had the poorest
Prognosis (25% survival 8 1/4).
2. Type Of Organism: The most favorable outcome was encountered in Streptococcal
IE (75% survival 24/32). Gram-negative IE resulted in 50°. Survival
(1/2).
Staphylococcal IE gave the lowest survival rate (14% = 1/7).
In culture positive cases the relation between survival and type of
organism was statistically significant.
3. Vegetations: It was demonstrated that absence of vegetations had better
prognosis than when present (survival 67% = 8/12 versus 56%
= 25/45 respectively). However, the results were statistically insignificant.
Also, no relation was found between change between
vegetation size and success of therapy.
Tables 1,2
4. Heart Failure: The survival of those without heart failure was 25 out of 34 (73.5%) where as in those with heart failure only 8 out of 23 survived (34.8%). The results were statistically significant.
5. Heart Size: Patients with normal heart size had 80% survival (12/15) while those with cardiomegaly had 50% survival (21/42). P<0.05.
6. Ejection Fraction: Patients survived the follow up period had an EF of 70% on admission and 71% at two-month follow up while those who died had an E.F. of 61 (S.D. =14) and 54% respectively. P<0.05.
7. Pulmonary Acceleration Time (P.Acc.t): Patients with P.Acc.t >to 90 msec had 67.5% survival (27/40) whereas those with P.Acc.t < 90 msec had 35.3% survival (6/17). P<0.05.
8. Prognosis According To Management: Survival in patients treated medically alone was 41.5 % (17/41), The causes of death were heart failure in 15 patients (62.5%), ventricular fibrillation in 1 patient (4.2%), pulmonary embolism in 3 patients (12.5%) and cerebral haemorrhage in two patients (8.3%).
Figure 1. Apical 4 chamber echocardiogram of a patient with pedunculated vegetations on both anterior and posterior leaflets.
Figure 2. Parasternal long axis echocardiogram of a patient with pedunculated vegetations on both anterior and posterior leaflets.
Figure 4. Apical 5 chamber echocardiogram of a patient with aortic vegetations and anterior mitral leaflet vegetation.
Figure 5. Apical 4 chamber echocardiogram of a patient with Star Edwards valve endocarditis evidenced by posterior prosthetic density.
Figure 6. Apical 4 chamber echocardiogram of a patient with a sessile vegetation on the anterior mitral leaflet.
Discussion
We adopted the modified Duke criteria for diagnosis of IE. We did not resort to transesophageal echo. Li et al [6] demonstrated
the importance of using TEE when applying the Duke criteria to
patients with suspected IE. They advocated using TEE as the initial
diagnostic test of choice in patients with at least “possible IE,”
according to clinical criteria in patients with suspected complicated
IE (i.e., paravalvular abscess) and in patients with suspected
prosthetic valve IE.
Antimicrobial Treatment: The initial therapy of IE is usually empirical;
exact antibiotic is given after a pathogen is identified. Published
papers conform to this protocol [7-12].
Conclusions
Rheumatic heart diseasepatients should be covered with antibiotics
whenever undergoing any interventional procedures.
A new regurgitant murmur is uncommon, but when it occurs it is
nearly diagnostic.
There is no correlation between the change in vegetation size
and success of therapy. Also, there is no correlation between the
shape of vegetation and the outcome of IE.
Arterial samples are not different from venous ones. The microbiological
profile differs in NVE than in early PVE. Streptococcal
IE constitutes the majority of cases in NVE. The combination
of penicillin-gentamicin is still successful in treating most of the
patients.
Despite the success in eradicating the pathogen in all the study
patients as evidenced by negative blood cultures during follow up,
the mortality rate remained high. This is mainly due to haemodynamic
deterioration.
References
- Pierce D, Calkins BC, Thornton K. Infectious endocarditis: diagnosis and treatment. American family physician. 2012 May 15; 85(10): 981-6.
- Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009 Oct; 30(19): 2369-413. PMID: 19713420.
- Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar 9; 169(5): 463-73. PMID: 19273776.
- Karchmer AW. Infectious endocarditis. Harrison’s Principles of Internal Medicine (17th Edtn) New York, McGrawHill. 2008: 789-797.
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 Apr; 30(4): 633-8. PMID: 10770721.
- Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data. Ann Intern Med. 2019 Jan 1; 170(1): 31-40. PMID: 30508432.
- Shrestha N, Shakya S, Hussain S, Pettersson G, Griffin B, Gordon S. Sensitivity and specificity of Duke Criteria for diagnosis of definite infective endocarditis: a cohort study. InOpen Forum Infect Dis. 2017; 4(1): S550- S551.
- Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015 Oct 13; 132(15):1435-86. PMID: 26373316.
- Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Nov 21; 36(44): 3075-3128. PMID: 26320109.
- Park LP, Chu VH, Peterson G, Skoutelis A, Lejko-Zupa T, Bouza E, et al. Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis. J Am Heart Assoc. 2016 Apr 18; 5(4): e003016. PMID: 27091179.
- Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015 Jan 13; 131(2): 131-40. PMID: 25480814.
- Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. N Engl J Med. 2019 Jan 31; 380(5): 415-424. PMID: 30152252.